88 related articles for article (PubMed ID: 7979151)
21. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
Sandgren EP; Luetteke NC; Qiu TH; Palmiter RD; Brinster RL; Lee DC
Mol Cell Biol; 1993 Jan; 13(1):320-30. PubMed ID: 8417334
[TBL] [Abstract][Full Text] [Related]
22. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
23. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
Sargent LM; Sanderson ND; Thorgeirsson SS
Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
[TBL] [Abstract][Full Text] [Related]
24. Compensatory apoptosis in response to SV40 large T antigen expression in the liver.
Allemand I; Grimber G; Kornprobst M; Bennoun M; Molina T; Briand P; Joulin V
Oncogene; 1995 Dec; 11(12):2583-90. PubMed ID: 8545115
[TBL] [Abstract][Full Text] [Related]
25. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion.
Etiemble J; Degott C; Renard CA; Fourel G; Shamoon B; Vitvitski-Trépo L; Hsu TY; Tiollais P; Babinet C; Buendia MA
Oncogene; 1994 Mar; 9(3):727-37. PubMed ID: 8108115
[TBL] [Abstract][Full Text] [Related]
26. The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.
Bennoun M; Grimber G; Couton D; Seye A; Molina T; Briand P; Joulin V
Oncogene; 1998 Sep; 17(10):1253-9. PubMed ID: 9771968
[TBL] [Abstract][Full Text] [Related]
27. Oncogenes in mouse liver tumors.
Anderson M; Stanley L; Devereux T; Reynolds S; Maronpot R
Prog Clin Biol Res; 1992; 376():187-201. PubMed ID: 1528919
[No Abstract] [Full Text] [Related]
28. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
Happ B; Hynes NE; Groner B
Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
[TBL] [Abstract][Full Text] [Related]
29. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
30. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
Calvisi DF; Thorgeirsson SS
Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice.
Magdaleno SM; Wang G; Mireles VL; Ray MK; Finegold MJ; DeMayo FJ
Cell Growth Differ; 1997 Feb; 8(2):145-55. PubMed ID: 9040936
[TBL] [Abstract][Full Text] [Related]
33. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
35. Interactive effects of c-myc and transforming growth factor alpha transgenes on liver tumor development in simian virus 40 T antigen transgenic mice.
Enomoto A; Sandgren EP; Maronpot RR
Vet Pathol; 1998 Jul; 35(4):283-91. PubMed ID: 9684972
[TBL] [Abstract][Full Text] [Related]
36. SV40 large T antigen directed by regulatory elements of the human alpha-1-antitrypsin gene. A transgenic mouse system that exhibits stages in liver carcinogenesis.
Butel JS; Sepulveda AR; Finegold MJ; Woo SL
Intervirology; 1990; 31(2-4):85-100. PubMed ID: 2142679
[TBL] [Abstract][Full Text] [Related]
37. Altered differentiation of hepatocytes in a transgenic mouse model of hepatocarcinogenesis.
Enomoto A; Sandgren EP; Maronpot RR
Toxicol Pathol; 1998; 26(4):570-8. PubMed ID: 9715517
[TBL] [Abstract][Full Text] [Related]
38. T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene.
Held WA; Mullins JJ; Kuhn NJ; Gallagher JF; Gu GD; Gross KW
EMBO J; 1989 Jan; 8(1):183-91. PubMed ID: 2714250
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a histologic classification of mouse liver tumors based on pyruvate kinase isozymes and status of host lipids.
Yanagi S; Tsuda H; Sakamoto M; Ninomiya Y; Ito N
J Natl Cancer Inst; 1984 Dec; 73(6):1311-7. PubMed ID: 6595442
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of streptozotocin on tumor development in transgenic mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Brinck-Johnsen T; Longnecker DS
Pancreas; 1991 Jul; 6(4):475-8. PubMed ID: 1678889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
